Sobre 16 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Explore the full record of transactions filed by Childs John W, Director. Director active across 4 companies, notably Veradermics, Inc. Cumulatively, 35 disclosures have been logged. Breakdown: 22 buys · 3 sells. Total volume traded: €130.4m. Activity tracked since 10 November 2021. The latest transaction was filed on 12 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Childs John W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2.380.952 títulos@ 10,50 US$26.2% de su flujoCommon SharesSEC:0001562180-23-003045:0
Salida canónica: 23 ene 2023 (T+90)
25 de 35 declaraciones
About Childs John W
CHILDS JOHN W is a Director at Biohaven Ltd., MATTRESS FIRM HOLDING CORP., Biohaven Pharmaceutical Holding Co Ltd., and Veradermics, Inc. He has 32 filings in total, and across the 32 sampled filings, the observed buys and sells run from 2016-02-05 to 2026-03-09, with buys of EUR 121091761 and sells of EUR 456885182.